Levenson R M, Ihde D C, Matthews M J, Cohen M H, Gazdar A F, Bunn P A, Minna J D
J Natl Cancer Inst. 1981 Sep;67(3):607-12.
Eight (4%) of 203 consecutive prospectively staged and treated patients with small cell carcinoma (SCC) had no evidence of pulmonary or mediastinal tumor on chest roentgenogram or at fiberoptic bronchoscopy at the time of diagnosis. There were two distinct clinical presentations in these SCC patients with exclusively extrapulmonary tumors. Four had discrete localized extrapulmonary neoplasms, presumably originating in these sites. In the other 4 cases with either regional or widely metastatic disease, no obvious primary tumor could be documented in the lungs or elsewhere. One complete and two partial responses to chemotherapy (duration 6 to greater than 11 mo) occurred in 6 evaluable patients. Two remaining patients were inevaluable for response because they received adjuvant chemotherapy after irradiation or excision of the primary tumor and are free of disease at 15 and 28 months. Results document two clinicopathologic entities of extrapulmonary SCC, more firmly establish that it can be responsive to chemotherapy, and encourage systemic therapy as part of initial treatment planning.
在203例连续前瞻性分期并接受治疗的小细胞癌(SCC)患者中,有8例(4%)在诊断时胸部X线片或纤维支气管镜检查未发现肺部或纵隔肿瘤证据。这些仅表现为肺外肿瘤的SCC患者有两种不同的临床表现。4例有离散的局限性肺外肿瘤,推测起源于这些部位。另外4例有区域或广泛转移疾病的患者,在肺部或其他部位未发现明显的原发肿瘤。6例可评估患者中有1例完全缓解,2例部分缓解(持续时间6至超过11个月)。其余2例患者因在原发肿瘤放疗或切除后接受辅助化疗而无法评估疗效,目前在15个月和28个月时无疾病。结果证实了肺外SCC的两种临床病理实体,更有力地证明其对化疗有反应,并鼓励将全身治疗作为初始治疗计划的一部分。